A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Fitch affirms GlaxoSmithKline's A- long-term issuer default rating with stable outlook, driven by strong diversification, improving profitability and free cash flow; financial flexibility expected to improve after split of its consumer-health division

“Chelating Platform For Delivery Of Radionuclides” In Patent Application Approval Process (USPTO 20220160904)

Glaxosmithkline Biologicals Files United States Patent Application For Novel Influenza Antigens

GlaxoSmithKline to acquire Affinivax for US$2.1B and its bacterial infectious disease vaccine under development that targets 24 species of Streptococcus pneumoniae; pneumococcal vaccine market projected to grow to US$10B by 2028

Gsk Announces Positive Phase Iii Data For Rsv Vaccine Candidate For Older Adults

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count